Thomas R. E. Barnes

1980–2025 年に発表

101
論文数
20,371
被引用数
80
h 指数
98
i10 指数

被引用数

Thomas R. E. Barnes の年別被引用数1983 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 4 件1986 年: 被引用 6 件1987 年: 被引用 5 件1988 年: 被引用 1 件1989 年: 被引用 12 件1990 年: 被引用 4 件1991 年: 被引用 16 件1992 年: 被引用 22 件1993 年: 被引用 26 件1994 年: 被引用 32 件1995 年: 被引用 27 件1996 年: 被引用 31 件1997 年: 被引用 36 件1998 年: 被引用 44 件1999 年: 被引用 51 件2000 年: 被引用 74 件2001 年: 被引用 86 件2002 年: 被引用 88 件2003 年: 被引用 106 件2004 年: 被引用 99 件2005 年: 被引用 160 件2006 年: 被引用 137 件2007 年: 被引用 181 件2008 年: 被引用 209 件2009 年: 被引用 256 件2010 年: 被引用 236 件2011 年: 被引用 196 件2012 年: 被引用 178 件2013 年: 被引用 171 件2014 年: 被引用 180 件2015 年: 被引用 166 件2016 年: 被引用 135 件2017 年: 被引用 100 件2018 年: 被引用 116 件2019 年: 被引用 428 件2020 年: 被引用 366 件2021 年: 被引用 343 件2022 年: 被引用 206 件2023 年: 被引用 172 件2024 年: 被引用 275 件2025 年: 被引用 111 件2026 年: 被引用 8 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,624 件、この内訳の 23.4%イギリス: 引用元論文 1,166 件、この内訳の 16.8%カナダ: 引用元論文 438 件、この内訳の 6.3%ドイツ: 引用元論文 431 件、この内訳の 6.2%オーストラリア: 引用元論文 388 件、この内訳の 5.6%イタリア: 引用元論文 257 件、この内訳の 3.7%スペイン: 引用元論文 237 件、この内訳の 3.4%オランダ: 引用元論文 229 件、この内訳の 3.3%中国: 引用元論文 168 件、この内訳の 2.5%スイス: 引用元論文 145 件、この内訳の 2.1%デンマーク: 引用元論文 133 件、この内訳の 1.9%フランス: 引用元論文 129 件、この内訳の 1.9%
0%23.4%その他 22.9%

分野

  • Medicine73.8%
  • Neuroscience12.2%
  • Psychology6.8%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Arts and Humanities0.6%
  • その他2.5%

トピック

  • Schizophrenia research and treatment20.2%
  • Bipolar Disorder and Treatment4.8%
  • Mental Health and Psychiatry4.5%
  • Cannabis and Cannabinoid Research4.3%
  • Tryptophan and brain disorders3.1%
  • Neurotransmitter Receptor Influence on Behavior2.9%
  • その他60.2%

共著者

全論文

検索で開く
  1. The Maudsley Prescribing Guidelines in Psychiatry

    著者: , , - 2021 被引用: 981

  2. A Rating Scale for Drug-Induced Akathisia

    著者: - The British Journal of Psychiatry 1989 被引用: 2,175

  3. Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Psychopharmacology 2019 被引用: 596

  4. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

    著者: , , , , , , - The Lancet 2007 被引用: 2,223

  5. The relationship between negative symptoms and depression in schizophrenia: a systematic review

    著者: , , , - Acta Psychiatrica Scandinavica 2018 被引用: 225

  6. Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2023 被引用: 86

  7. The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Psychiatry 2018 被引用: 180

  8. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Drake, Sonia Dollfus, Serdar Dursun, Bjørn H. Ebdrup, Robin Emsley, Emilio Fernández-Egea, Hélio Elkis, Peter Falkai, Wolfgang Fleischhacker, Oliver Freudenreich, Ary Gadelha, Wolfgang Gäebel, Birte Glenthøj, Donald Goff, Ariel Graff‐Guerrero, Jorge Hallak, Alkomiet Hasan, William G. Honer, Philip Homan, Oliver Howes, René S. Kahn, Stefan Kaiser, John M. Kane, James L. Kennedy, Bruce J. Kinon, Euitae Kim, Stephen M. Lawrie, Jimmy Lee, Stefan Leucht, F. Markus Leweke, Jan Libiger, Antony Loebel, James H. MacCabe, Stephen R. Marder, Robert A. McCutcheon, Ingrid Melle, Herbert Y. Meltzer, Armida Mucci, Dieter Naber, Shinchiro Nakajima, Jimmi Nielsen, Oisín O’Brien, Akin Ojagbemi, Christos Pantelis, Joseph Peuskens, Steven G. Potkin, Tiago Reis Marques, Thomas J. Raedler, Gary Remington, Susan L. Rossell, Jose Rubio-Lorente, Gabriele Sachs, Dan Siskind, Cynthia Siu, Iris E. Sommer, Jun Soo Kwon, Takefumi Suzuki, Jaana Suvisaari, Hiroyoshi Takeuchi, Rajiv Tandon, David Taylor, Neil Thomas, Jari Tiihonen, Hiroyuki Uchida, Alp Üçok, Daniel Umbricht, Ganesan Venkatasubramanian, Elias Wagner, James Walters, Chuanyue Wang ほか 2 名 - Schizophrenia Bulletin 2023 被引用: 38

  9. Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneity

    著者: , , , , , , , , , , , , , , , , , , - Brain Behavior and Immunity 2023 被引用: 42

  10. Treatment Recommendations for Tardive Dyskinesia

    著者: , , , , , , , , , , - The Canadian Journal of Psychiatry 2019 被引用: 100

  11. Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

    著者: , , , , , , , , - Schizophrenia Bulletin 2005 被引用: 421

  12. The Assessment and Treatment of Antipsychotic-Induced Akathisia

    著者: , , , , , , , , , , - The Canadian Journal of Psychiatry 2018 被引用: 83

  13. Transcription and pathway analysis of the superior temporal cortex and anterior prefrontal cortex in schizophrenia

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Neuroscience Research 2011 被引用: 96

  14. Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paola Rocca, George Umoh, George Umoh, Lucho G Hranov, Alex Hofer, Joachim Cordes, Ramin Nilforooshan, Julio Bobes, Solveig Klebo Reitan, Manuel Morrens, Aurel Nireştean, John Geddes, John Geddes, Marcin Olajossy, Alessandro Rossi, Erik Johnsen, Csekey László, Adela Magdalena Ciobanu, Peter Haddad, Igor Oife, Miquel Bernardo, Rodicutza Stan, Marek Jarema, Dan Rujescu, Libor Ustohal, Neil Mayfield, Paola Dazzan, Avi Valevski, Jan Libiger, Richard M. Köhler, Pavel Mohr, Sofia Pappa, Petros Drosos, Thomas R. E. Barnes, Esther DeClercq, Elias Wagner, Paola Bucci, Armida Mucci, Yaacov Rabinowitz, Adam Adamopoulous, Benjamin Draiman, Cristiana Montemagni, Manfred Greslechner, Hannah Herlihy, Csilla Bolyós, Christian Schmidt-Kraepelin, Jessica True, Leticia Alvarez Garcia, Berit Walla, Bernhard Sabbe, Lucaks Emese, Sarah Mather, Nikodem Skoczeń, Serena Parnanzone, Jill Bjarke, Krisztina Karácsonyi, Steve Lankshear, Marina Garriga, Adam Wichniak, Heidi Baumbach, Heidi Baumbach, Leonie Willebrands, Lyliana Nasib, Cynthia Okhuijsen‐Pfeifer, Elianne Huijsman, Michael Davidson, René S. Kahn, W.W. Fleischhacker, W.W. Fleischhacker, W.W. Fleischhacker - The Lancet Psychiatry 2023 被引用: 48

  15. Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Romain Richard, Carmen Simonsen, Filip Španiel, Andreı̈ Szöke, Ilaria Tarricone, Andrea Tortelli, Alp Üçok, Javier Vázquez-Bourgón, Robin Murray, James Walters, Daniel Ståhl, James H. MacCabe - Schizophrenia Research 2022 被引用: 24

  16. Proceedings of the Seventh Workshop on Computational Linguistics and Clinical Psychology: Improving Access

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sing Lee, Nancy Samp- Son, María Carmen Viana, Laura Helena Andrade, Chiyi Hu, Elie G. Karam, Maria Ladea, María Elena, Medina Mora, Mark Oakley, Keith Harrigian, Carlos Aguirre, Mark Dredze, Glen Coppersmith, Craig Harman, Kristy Hollingshead, Margaret Mitchell, Johannes C. Eichstaedt, Robert E. Smith, Raina Mer- Chant, Lyle Ungar, Hila Gonen, Yoav Goldberg, Yoav Goldberg, Adrian Benton, Glen Coppersmith, Mark Dredze, Liliana Dell, ' Osso, Barbara Carpita, Carlo Bertelloni, Elisa Diadema, Maria Filippo, Camilla Barberi, Claudia Gesi, Carmassi, Colin Depp, Dilip Jeste, Arianna Diflorio, Ian Jones, Gunther Eysenbach, James Till, J Alize, Emily Ferrari, Jon Stockings, Holly Khoo, Louisa Erskine, Theo Degenhardt, Harvey Vos, Whiteford, Robert Freedman, David Lewis, Robert Michels, Daniel Pine, Susan Schultz, Carol Tamminga, Glen Gabbard, Susan Shur-Fen, Daniel Gau, Maria Javitt, Patrick Oquendo, Eduard Shrout, Joel Vieta, Yager, Danielle Novick, Holly Swartz, Ellen Frank, O' Bridianne, Stephen Dea, Philip Wan ほか 2,489 名 - 2021 被引用: 21

  17. Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia

    著者: , , , , , , , , - Archives of General Psychiatry 2006 被引用: 1,108

  18. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

    著者: - Journal of Psychopharmacology 2011 被引用: 353

  19. A window into the brain: An in vivo study of the retina in schizophrenia using optical coherence tomography

    著者: , , , , - Psychiatry Research Neuroimaging 2012 被引用: 134

  20. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Trevor Munro-Clark, Elizabeth Murphy, Mairi Spanswick, Ann Steele, Liesbeth Tip, Sarah Tully - The Lancet Psychiatry 2018 被引用: 111

  21. A Randomized Controlled Trial of Cognitive-Behavioral Therapy for Persistent Symptoms in Schizophrenia Resistant to Medication

    著者: , , , , , , , - Archives of General Psychiatry 2000 被引用: 697

  22. Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis

    著者: , , , , - The Canadian Journal of Psychiatry 2018 被引用: 87

  23. Comorbid substance use and age at onset of schizophrenia

    著者: , , , , - The British Journal of Psychiatry 2006 被引用: 272

  24. Do patients with schizophrenia exhibit aberrant salience?

    著者: , , , , , - Psychological Medicine 2008 被引用: 265